Abstract
DIABETES TECHNOLOGY SOCIETY
23rd annual diabetes technology meeting Agenda
Thursday, November 2, 2023
Can apps modify behavior?
8:00
William Polonsky, PhD
Behavioral Diabetes Institute, San Diego, California, USA
Michelle L. Litchman, PhD, FNP-BC, FAANP, FADCES, FAAN
The University of Utah College of Nursing, Salt Lake City, Utah, USA
Andrew Farmer, DM, FRCGP
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom
Felix Lee, MPharm, MSc, MBA Sanofi, Bridgewater, New Jersey, USA
David T. Ahn, MD
Mary & Dick Allen Diabetes Center, Hoag Memorial Hospital Presbyterian, Newport Beach, California, USA
9:40
How to apply coaching to improve diabetes outcomes?
9:55
Warris Bokhari, MBBS
Amazon, Seattle, Washington, USA
David Kerr, MBChB, DM, FRCP, FRCPE
Sutter Health, Santa Barbara, California, USA
Wei-An (Andy) Lee, DO
Los Angeles General Medical Center, Los Angeles, California, USA
Anand K. Iyer, PhD, MBA
Welldoc, Inc., Columbia, Maryland, USA
Sacha Uelmen, RDN, CDCES
Association of Diabetes Care & Education Specialists, Chicago, Illinois, USA
11:30
What are the latest metrics for CGM?
12:30
Guillermo Umpierrez, MD
Emory University School of Medicine, Atlanta, Georgia, USA
Eda Cengiz, MD, MHS, FAAP
University of California, San Francisco, School of Medicine, San Francisco, California, USA
12:35
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA
12:50
Richard M. Bergenstal, MD
International Diabetes Center, HealthPartners Institute, Minneapolis, Minnesota, USA
13:05
Viral N. Shah, MD
Barbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado, USA
13:20
Manuel Eichenlaub, PhD
Institut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany
13:35
James S. Krinsley, MD
Division of Critical Care, Stamford Hospital, Columbia University College of Physicians and Surgeons, Stamford, Connecticut, USA
13:50
14:10
How can technology identify complications of diabetes?
14:25
Michael J. McShane, PhD
Department of Biomedical Engineering, Texas A&M University, College Station, Texas, USA
Andjela Drincic, MD
Department of Diabetes, Endocrinology, and Metabolism, University of Nebraska Medical Center, Omaha, Nebraska, USA
14:30
Jorge A. Cuadros, OD, PhD
Herbert Wertheim School of Optometry and Vision Science, University of California, Berkeley, Berkeley, California, USA
14:45
Michael C. Riddell, PhD
Department of Kinesiology & Health Science, Muscle Health Research Centre, York University, Toronto, ON, Canada
15:00
Gerard L. Coté, PhD
Department of Biomedical Engineering, Texas A&M University, College Station, Texas, USA
15:15
Ted Osinski
Institute of Electrical and Electronics Engineers, Piscataway, New Jersey, USA
15:30
Devin W. Steenkamp, MBChB
Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA
15:45
16:05
8:00
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA
8:05
Juan Espinoza, MD, FAAP
Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois, USA
8:25
8:30
William T. Cefalu, MD
Division of Diabetes, Endocrinology, & Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA
John C. Pickup, MA, DPhil, FRCPath
King’s College London School of Medicine, London, UK
Eirik Årsand, PhD
UiT Arctic University of Norway, Tromsø, Norway
8:35
Boris Kovatchev, PhD
University of Virginia, Charlottesville, Virginia, USA
8:55
Norbert Hermanns, PhD
Research Institute of the Diabetes Academy Mergentheim (FIDAM), Bad Mergentheim, Germany
9:15
Andrea Facchinetti, PhD
Department of Information Engineering, University of Padova, Padova, Italy
9:35
How can people without diabetes benefit from CGM?
9:50
Julia K. Mader, MD
Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Austria
Kong Y. Chen, PhD
National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, USA
9:55
Tracey L. McLaughlin, MD, MS
Stanford University School of Medicine, Stanford, California, USA
10:10
Stephanie A. Fisher, MD, MPH
Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
10:25
Connie M. Rhee, MD, MSc
VA Greater Los Angeles Healthcare System, Los Angeles, California, USA and David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA
10:40
Kathleen M. Dungan, MD, MPH
The Ohio State University, Columbus, Ohio, USA
10:55
11:10
What are new trends in FDA regulation of diabetes devices and drugs?
11:25
Alberto Gutierrez, PhD
NDA Partners LLC, Bethesda, Maryland, USA
Naomi Schwartz, MS
Medcrypt, Inc., San Diego, California, USA
11:30
Matthew C. Diamond, MD, PhD
Center for Devices and Radiological Health, United States Food and Drug Administration, Silver Spring, Maryland, USA
11:40
Jessica Wilkerson, JD
Center for Devices and Radiological Health, United States Food and Drug Administration, Silver Spring, Maryland, USA
11:50
Deanna Bousalis, PhD
Center for Devices and Radiological Health, United States Food and Drug Administration, Silver Spring, Maryland, USA
12:00
Zan Fleming, MD
Kinexum, Harpers Ferry, West Virginia, USA
12:15
12:30
What are the challenges to building a commercially successful insulin pump?
13:00
Robert A. Gabbay, MD, PhD
American Diabetes Association, Arlington, Virginia, USA
Douglas Muchmore, MD
La Jolla Endo, LLC, La Jolla, California, USA
13:05
Sarnath Chattaraj, PhD
Medtronic Diabetes, Northridge, California, USA
13:15
Jeffrey Joseph, DO
Jefferson Artificial Pancreas Center, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, USA
13:25
Lutz Heinemann, PhD
Science Consulting in Diabetes, Düsseldorf, Germany
13:35
Ralph Ziegler, MD
Diabetes Clinic for Children and Adolescents, Muenster, Germany
13:45
Michael Schoemaker, PhD
Pharmasens AG, Biel, Switzerland
13:55
What is the role of BGM in various parts of the world?
14:10
Hubert W. Vesper, PhD
Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Halis K. Aktürk, MD
Barbara Davis Center for Diabetes, University of Colorado, Aurora, Colorado, USA
14:15
Timothy S. Bailey, MD, FACE, CPI
AMCR Institute, Escondido, California, USA
14:25
Andreas Pfützner, MD, PhD
Pfützner Science and Health Institute, Mainz, Germany
14:40
Mark A. Clements, MD, PhD, CPI, FAAP
Children’s Mercy Hospitals & Clinics, Kansas City, Missouri, USA
14:55
Yong Mong Bee, MBBS, MRCP(UK), FRCP Edin
Department of Endocrinology, Singapore General Hospital, Singapore
15:10
15:20
What are the features of a successful AID algorithm?
15:35
Jeffrey Joseph, DO
Jefferson Artificial Pancreas Center, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, USA
Carol Levy, MD, CDCES
Division of Endocrinology, Diabetes, and Metabolism, Icahn School of Medicine at Mount Sinai, New York City, New York, USA
15:40
Steven J. Russell, MD, PhD
Massachusetts General Hospital Diabetes Research Center, Boston, Massachusetts, USA
15:50
Rayhan A. Lal, MD
Stanford University, Stanford, California, USA
16:00
David N. O’Neal, MD, FRACP, FRCP (Edin)
University of Melbourne, Melbourne, VIC, Australia
16:10
Ahmad Haidar, PhD
McGill University, Quebec, Canada
16:20
Patient 1
16:25
Patient 2
16:30
16:45
Which new drugs or indications for diabetes look promising?
8:00
Mohammed E. Al Sofiani, MBBS, MSc
King Saud University, Riyadh, Saudi Arabia / Johns Hopkins University, Baltimore, Maryland, USA
Signe Schmidt, MD, PhD
Steno Diabetes Center Copenhagen (SDCC), Copenhagen, Denmark
8:05
Elisa Pellizzari, MSc
University of Padova, Padova, Italy
8:20
Eric Zijlstra, PhD
Profil, Neuss, Germany
8:35
Ronald Goldenberg, MD, FRCPC, FACE
LMC Diabetes & Endocrinology, Concord, Ontario, Canada
8:50
Alfonso Galderisi, MD, PhD
Yale University, New Haven, Connecticut, USA
9:05
Stephen E. Gitelman, MD
Division of Endocrinology, Department of Pediatrics, University of California, San Francisco, San Francisco, California, USA
9:20
What is the role of AI/ML in diabetes management?
9:35
Boris Kovatchev, PhD
University of Virginia, Charlottesville, Virginia, USA
Riccardo Bellazzi, PhD
Università di Pavia, Pavia, Italy
9:40
Xujing Wang, PhD
Division of Diabetes, Endocrinology, & Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA
9:55
Peter G. Jacobs, PhD
Oregon Health & Science University, Portland, Oregon, USA
10:10
Clara Mosquera-Lopez, PhD
Oregon Health & Science University, Portland, Oregon, USA
10:25
Moshe Phillip, MD
Schneider Children’s Medical Center of Israel, Petah Tikva, Israel
10:40
10:55
What should be measured for diabetes besides blood glucose?
11:15
Guillermo Arreaza-Rubín, MD
Division of Diabetes, Endocrinology, and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA
Alan H.B. Wu, PhD
University of California, San Francisco, San Francisco, CA, USA
11:20
Mark A. Arnold, PhD
The University of Iowa, Iowa City, Iowa, USA
11:35
Shridhara Alva, PhD
Abbott Diabetes Care, Alameda, California, USA
11:50
Ambarish Pandey, MD
UT Southwestern Medical Center, Dallas, Texas, USA
12:05
12:20
What is new in CGM technology?
12:50
Nestoras Mathioudakis, MD, MHS
Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Elias K. Spanakis, MD
Baltimore VA Medical Center and School of Medicine, University of Maryland, Baltimore, Maryland, USA
12:55
Anila Bindal, MD
Abbott Diabetes Care, Alameda, California, USA
13:07
Danny Cherñavvsky, MD
Dexcom, Inc., San Diego, California, USA
13:19
Robert Vigersky, MD
Medtronic, Washington, D.C., USA; Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA
13:31
Hari Sree, PhD
Senseonics Inc., Germantown, Maryland, USA
13:43
Thomas Seidl, PhD
Pacific Diabetes Technologies, Portland, Oregon, USA
13:55
How does diabetes affect skin health?
14:10
Gerald R. Sydorak, MD, FACS
Seton Medical Center, Daly City, California, USA
Bijan Najafi, PhD, MSc
Baylor College of Medicine, Houston, Texas, USA
14:15
Ulrike Klueh, PhD
Department of Biomedical Engineering, Integrative Biosciences Center, Wayne State University, Detroit, Michigan, USA
14:30
Jane Jeffrie Seley, DNP, MPH, MSN, GNP, BC-ADM, CDCES
Weill Cornell Medicine, Division of Endocrinology, Diabetes & Metabolism, New York City, New York, USA
14:45
Jannet Svensson, MD, PhD
Steno Diabetes Center Copenhagen, Herlev, Denmark
14:55
Bijan Najafi, PhD, MSc
Baylor College of Medicine, Houston, Texas, USA
15:05
15:20
What are promising new technologies for diabetes?
15:40
Umesh Masharani, MB, BS
University of California, San Francisco, San Francisco, California, USA
Geoff Chase, PhD
University of Canterbury, Christchurch, New Zealand
15:45
Bijan Najafi, PhD, MSc
Baylor College of Medicine, Houston, Texas, USA
15:55
Diane J. Burgess, PhD
University of Connecticut, Storrs, Connecticut, USA
16:05
Ali Cinar, PhD
Illinois Institute of Technology, Chicago, Illinois, USA
16:15
Ed Krisiunas, MLS(ASCP), MPH
WNWN International, Burlington, Connecticut, USA
16:25
What is a new carbohydrate dispensing product for diabetes?
16:40
Dorian Liepmann, PhD
University of California, Berkeley, Berkeley, California, USA
Jane Jeffrie Seley, DNP, MPH, MSN, GNP, BC-ADM, CDCES
Weill Cornell Medicine, Division of Endocrinology, Diabetes & Metabolism, New York City, New York, USA
16:45
Eirik Årsand, PhD
UiT Arctic University of Norway, Tromsø, Norway
Pietro Randine
UiT Arctic University of Norway, Tromsø, Norway
17:00
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA